1.
Systolic pressure is all that matters
by Williams, Bryan, Prof
The Lancet (British edition), 2008, Vol.371 (9631), p.2219-2221

2.
A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial
by Weber, Michael A, Prof
The Lancet (British edition), 2009, Vol.374 (9699), p.1423-1431

3.
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
by Dahlöf, Björn
The Lancet (British edition), 2002-03-23, Vol.359 (9311), p.995-1003

4.
Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenol...
by Lindholm, Lars H
The Lancet (British edition), 2002-03-23, Vol.359 (9311), p.1004-1010

5.
Total cardiovascular risk approach to improve efficiency of cardiovascular prevention in resource constrain settings
by Mendis, Shanthi
Journal of clinical epidemiology, 2011, Vol.64 (12), p.1451-1462

6.
Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (C...
by Hansson, Lennart
The Lancet (British edition), 1999, Vol.353 (9153), p.611-616

7.
Divergent Results Using Clinic and Ambulatory Blood Pressures: Report of a Darusentan-Resistant Hypertension Trial
by Bakris, George L
Hypertension (Dallas, Tex. 1979), 2010-11, Vol.56 (5), p.824-830

8.
Effect of losartan on sudden cardiac death in people with diabetes: data from the LIFE study
by Lindholm, Lars H
The Lancet (British edition), 2003-08-23, Vol.362 (9384), p.619-620

9.
Greater Regression of Electrocardiographic Left Ventricular Hypertrophy During Hydrochlorothiazide Therapy in Hypertensive Patients
by Okin, Peter M.
American journal of hypertension, 2010-07, Vol.23 (7), p.786-793

10.
Relation between drug treatment and cancer in hypertensives in the Swedish Trial in Old Patients with hypertension 2: a 5-year, prospective, randomised, controlled trial
by LINDHOLM, Lars H
The Lancet (British edition), 2001, Vol.358 (9281), p.539-544

11.
Valsartan treatment of hypertension—does VALUE add value?
by Lindholm, Lars H
The Lancet (British edition), 2004-06-19, Vol.363 (9426), p.2010-2011

12.
Combination of the Electrocardiographic Strain Pattern and Albuminuria for the Prediction of New-onset Heart Failure in Hypertensive Patients: The LIFE Study
by Okin, Peter M.
American journal of hypertension, 2008-03, Vol.21 (3), p.273-279

13.
Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: The Losartan Intervention For End point reduction in hypertensi...
by Olsen, Michael Hecht, MD, PhD
The American heart journal, 2009, Vol.157 (1), p.177-184

14.
In-Treatment Resolution or Absence of Electrocardiographic Left Ventricular Hypertrophy Is Associated With Decreased Incidence of New-Onset Diabetes Mellitus in Hypertensive Patien...
by Okin, Peter M
Hypertension (Dallas, Tex. 1979), 2007-11, Vol.50 (5), p.984-990

15.
Hospitalizations for New Heart Failure Among Subjects With Diabetes Mellitus in the RENAAL and LIFE Studies
by Carr, Albert A
The American journal of cardiology, 2005, Vol.96 (11), p.1530-1536

16.
Atenolol in hypertension: is it a wise choice?
by Carlberg, Bo
The Lancet (British edition), 2004, Vol.364 (9446), p.1684-1689

17.
An analysis of cholesterol control and statin use in the losartan intervention for endpoint reduction in hypertension study
by Kristianson, Krister
Clinical therapeutics, 2003-04, Vol.25 (4), p.1186-1199

18.
Pulse Pressure and Effects of Losartan or Atenolol in Patients With Hypertension and Left Ventricular Hypertrophy
by Fyhrquist, Frej
Hypertension (Dallas, Tex. 1979), 2005-04, Vol.45 (4), p.580-585

19.
A goose named Lindholm
by Lindholm, Lars H
The Lancet (British edition), 2002-05-18, Vol.359 (9319), p.1720-1720

20.
What are the odds at ASCOT today?
by Lindholm, Lars H
The Lancet (British edition), 2003, Vol.361 (9364), p.1144-1145
